Stockreport

Passage Bio Welcomes Tom Kassberg to Board of Directors

Passage Bio, Inc.  (PASG) 
PDF PHILADELPHIA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patient [Read more]